Pamela Munster, a breast cancer survivor and physician-scientist, is building a Stanford program focused on detecting cancer earlier and intervening sooner.
Researchers developed a urine test that detects bladder cancer, predicts which patients will benefit from immunotherapy versus chemotherapy, and can confirm whether treatment worked.
Tanja Gruber was recognized as the 2026 Scientific Honoree for her impact in advancing our understanding and treatment of challenging childhood cancers.
Smoky air is becoming more of a seasonal reality, but you can prepare your environment to keep everyone safe. Here’s a rundown from Stanford Medicine experts.
Raya Saab is revealing how a deadly pediatric muscle cancer rewires its environment to spread — pointing to new, targetable pathways for future drug development.
Stanford Medicine gynecologists can offer tailored strategies to manage menopause symptoms in breast cancer survivors who can’t use hormone replacement therapy.
A lymphoma driver called BCL6 suppresses the expression of cell death genes. A new molecule designed at Stanford Medicine blocks its activity and activates downstream genes to trigger cell death.
The FDA finally gave the green light to bemotrizinol. We consulted three Stanford Medicine experts about why this is considered a massive leap forward for skin health in the U.S.
The groundbreaking drug daraxonrasib, which doubled survival time for patients with metastatic pancreatic cancer, is available through expanded access at Stanford.
Pamela Munster brings her expertise in translational medicine, early-phase clinical trials, and precision oncology to the Early Drug Development Program, helping turn scientific discoveries into safer, more personalized treatments for patients.
Cellular and molecular interactions around tumors give insight into their structures and weaknesses, but measuring them has been expensive and slow. A Stanford Medicine AI platform flips the script.
Taking inspiration from our own biology, Stanford scientists developed a creative solution to one of the biggest challenges CAR-T therapy faces in treating solid tumors.
Antibody therapies show limited success in solid tumors. A new imaging technique developed at Stanford Medicine that locates antibodies at subcellular resolution in human tumors hints at why.
Two opposing biological pathways balance stem cell maintenance with skin development; topical drug treatments targeting them may treat skin cancers and disorders.
Hundreds of thousands of new cancer studies come out every year. Why are the results from a drug called daraxonrasib causing waves in the research community?
Stanford Medicine researchers and colleagues found a way to boost the cancer-fighting abilities of natural killer cells. In mice, the enhanced cells penetrated solid tumors and inhibited their growth.
A proposed cancer center in Redwood City would combine patient care and research. The city will receive a formal updated project description, and Stanford Medicine will host two community webinars.
Stanford pioneers engineered cytokines to supercharge cancer immunotherapy, promising powerful treatments with reduced toxicity for better patient outcomes.
Stanford Medicine’s new proton therapy facility is ready for patients. On June 4 a child with a rare brain tumor became the first to receive treatment.
Successful clinical trials start with effective operations. Senior trial manager Feriel Buchholz provides insight into the behind-the-scenes activities that advance cancer care.
Subcutaneous amivantamab with lazertinib treats EGFR lung cancer in minutes, matching intravenous efficacy with fewer side effects and greater patient access.
A blood test predicts the tumor microenvironment that affects treatment response. Researchers at Stanford Medicine and the Mayo Clinic find nine cellular neighborhoods shared among most cancer cases.
Groundbreaking cancer treatments start with basic science discoveries. A recent study redefines how proteins find one another, unlocking new doors for drug discovery.
Stanford Health Care commits $10 million to help the American Cancer Society build a new Hope Lodge to provide temporary lodging for cancer patients traveling to the Bay Area for treatment.
The Stanford Cancer Institute Research Conference unites the Stanford cancer community to highlight cutting-edge discoveries and strengthen cross-disciplinary collaboration.
Stanford Medicine is the first in the world to introduce ultracompact proton therapy that will make the advanced targeted radiotherapy more accessible to patients.
Immune cells engineered to sense metabolic byproducts secreted by cancer cells ‘follow their noses’ to migrate to and infiltrate solid tumors in mice in a Stanford Medicine study.
A leader who shined at bringing stakeholders together, Seshadri leaves a legacy through his ability to ‘navigate complex, high-stakes situations and relationships in really productive ways.’
The Office of Communication & Public Affairs is dedicated to sharing School of Medicine news with the media and helping journalists secure expert interviews, photographs and rich media for stories on medicine and health care.
